© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 8, 602-612,
April 19, 2000
© 2000 Oxford University Press
REVIEW |
Molecular Epidemiology: On the Path to Prevention?
Correspondence to: Frederica P. Perera, Dr.P.H., Division of Environmental Health Sciences, Joseph L. Mailman School of Public Health at Columbia University, New York, NY 10032 (e-mail: FPP1{at}columbia.edu).
Cancer prevention has been the stated goal of molecular cancer epidemiology for the past 17 years. In this review, progress toward that goal is evaluated by using as examples well-studied environmental exposures—i.e., tobacco smoke, polycyclic aromatic hydrocarbons, aflatoxin B1, benzene, and hepatitis B virus—and their roles in lung, breast, and liver cancers and leukemia. The contributions of molecular epidemiology discussed here include providing evidence that environmental agents pose carcinogenic risks, helping establish the causal roles of environmental factors in cancer, identifying environment–susceptibility interactions and populations at greatest risk, and developing new intervention strategies. Molecular epidemiologic and other data indicate that assessment of carcinogenic risks should address both the range of risk across the population and the risk to subgroups who may be at high risk because of genetic or acquired susceptibilities, including young children. However, for the most part, research results have not yet been effectively translated into risk assessments and preventive health policies. An infrastructure linking scientists, policy makers, and other constituencies is needed to facilitate this process. To extend our knowledge, the second generation of molecular epidemiologic research should include large-scale, collaborative studies incorporating validated biomarkers and automated technologies. An incentive to make the necessary investment is the recognition that prevention of only 20% of cancer in the United States would result in 200000 fewer new cases diagnosed each year and an annual savings of $21.4 billion in direct costs alone.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. ZUPA, A. SGAMBATO, G. BIANCHINO, G. IMPROTA, V. GRIECO, G. LA TORRE, B. CAMPISI, A. TRAFICANTE, M. AIETA, and A. CITTADINI GSTM1 and NAT2 Polymorphisms and Colon, Lung and Bladder Cancer Risk: A Case-control Study Anticancer Res, May 1, 2009; 29(5): 1709 - 1714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Millman, D. Tang, and F. P. Perera Air Pollution Threatens the Health of Children in China Pediatrics, September 1, 2008; 122(3): 620 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Vineis and F. Perera Molecular Epidemiology and Biomarkers in Etiologic Cancer Research: The New in Light of the Old Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1954 - 1965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Boffetta Molecular cancer epidemiology: a tale of >3842 publications Carcinogenesis, August 1, 2007; 28(8): 1621 - 1621. [Full Text] [PDF]
|
|
|
|
 |
|
 K. P. Tercyak and V. L. Tyc Opportunities and Challenges in the Prevention and Control of Cancer and Other Chronic Diseases: Children's Diet and Nutrition and Weight and Physical Activity J. Pediatr. Psychol., September 1, 2006; 31(8): 750 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. Thurston, G. Liu, D. P. Miller, and D. C. Christiani Modeling Lung Cancer Risk in Case-Control Studies Using a New Dose Metric of Smoking Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2296 - 2302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Ojha and R. Thertulien Health Care Policy Issues as a Result of the Genetic Revolution: Implications for Public Health Am J Public Health, March 1, 2005; 95(3): 385 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Perera, D. Tang, R. Whyatt, S. A. Lederman, and W. Jedrychowski DNA Damage from Polycyclic Aromatic Hydrocarbons Measured by Benzo[a]pyrene-DNA Adducts in Mothers and Newborns from Northern Manhattan, The World Trade Center Area, Poland, and China Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 709 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Bocskay, D. Tang, M. A. Orjuela, X. Liu, D. P. Warburton, and F. P. Perera Chromosomal Aberrations in Cord Blood Are Associated with Prenatal Exposure to Carcinogenic Polycyclic Aromatic Hydrocarbons Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 506 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Okcu, M. Selvan, L.-E Wang, L. Stout, R. Erana, G. Airewele, P. Adatto, K. Hess, F. Ali-Osman, M. Groves, et al. Glutathione S-Transferase Polymorphisms and Survival in Primary Malignant Glioma Clin. Cancer Res., April 15, 2004; 10(8): 2618 - 2625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. W. Mohrenweiser Genetic Variation and Exposure Related Risk Estimation: Will Toxicology Enter a New Era? DNA Repair and Cancer as a Paradigm Toxicol Pathol, January 1, 2004; 32(1_suppl): 136 - 145. [Abstract] [PDF]
|
|
|
|
|
|
G. E. Swan, K. S. Hudmon, L. M. Jack, K. Hemberger, D. Carmelli, T. V. Khroyan, H. Z. Ring, H. Hops, J. A. Andrews, E. Tildesley, et al. Environmental and Genetic Determinants of Tobacco Use: Methodology for a Multidisciplinary, Longitudinal Family-Based Investigation Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 994 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Jackson, P. J. O'Connor, D. P. Cooper, G. P. Margison, and A. C. Povey Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine Carcinogenesis, March 1, 2003; 24(3): 527 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Husgafvel-Pursiainen Molecular biomarkers in studies on environmental cancer J Epidemiol Community Health, October 1, 2002; 56(10): 730 - 731. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Miturski, M. Bogusiewicz, C. Ciotta, M. Bignami, M. Gogacz, and D. Burnouf Mismatch Repair Genes and Microsatellite Instability as Molecular Markers for Gynecological Cancer Detection Experimental Biology and Medicine, September 1, 2002; 227(8): 579 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. McCANLIES, D. P. LANDSITTEL, B. YUCESOY, V. VALLYATHAN, M. L. LUSTER, and D. S. SHARP Significance of Genetic Information in Risk Assessment and Individual Classification Using Silicosis as a Case Model Ann. Hyg., June 1, 2002; 46(4): 375 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hamajima, T. Saito, K. Matsuo, and K. Tajima Competitive Amplification and Unspecific Amplification in Polymerase Chain Reaction with Confronting Two-Pair Primers J. Mol. Diagn., May 1, 2002; 4(2): 103 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Burgaz, B Karahalil, Z Canli, F Terzioglu, G Ancel, R B. Anzion, R P Bos, and E Huttner Assessment of genotoxic damage in nurses occupationally exposed to antineoplastics by the analysis of chromosomal aberrations Human and Experimental Toxicology, March 1, 2002; 21(3): 129 - 135. [Abstract] [PDF]
|
|
|
|
|
|
R. Julian Preston Quantitation of Molecular Endpoints for the Dose-Response Component of Cancer Risk Assessment Toxicol Pathol, January 1, 2002; 30(1): 112 - 116. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Tang, D. H. Phillips, M. Stampfer, L. A. Mooney, Y. Hsu, S. Cho, W.-Y. Tsai, J. Ma, K. J. Cole, M. N. She, et al. Association between Carcinogen-DNA Adducts in White Blood Cells and Lung Cancer Risk in the Physicians Health Study Cancer Res., September 1, 2001; 61(18): 6708 - 6712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Whyatt, W. Jedrychowski, K. Hemminki, R. M. Santella, W.-Y. Tsai, K. Yang, and F. P. Perera Biomarkers of Polycyclic Aromatic Hydrocarbon-DNA Damage and Cigarette Smoke Exposures in Paired Maternal and Newborn Blood Samples as a Measure of Differential Susceptibility Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 581 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. L. Martin Genotoxins and the initiation of sporadic breast cancer Mutagenesis, March 1, 2001; 16(2): 155 - 161. [Abstract] [Full Text] [PDF]
|
|